Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127257591 | 12725759 | 1 | I | 20160821 | 20160905 | 20160908 | 20160908 | EXP | FR-009507513-1609FRA003220 | MERCK | 49.51 | YR | F | Y | 0.00000 | 20160908 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127257591 | 12725759 | 1 | PS | EMEND | APREPITANT | 1 | Oral | 205 MG, CYCLICAL | Y | 21549 | 205 | MG | CAPSULE | ||||||
| 127257591 | 12725759 | 2 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 8 G, QD | 8 | G | 0 | 8 | G | QD | |||||
| 127257591 | 12725759 | 3 | SS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 190 MG, QD | 570 | MG | 0 | 190 | MG | QD | |||||
| 127257591 | 12725759 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 800 MG, QD | 800 | MG | 0 | 800 | MG | QD | |||||
| 127257591 | 12725759 | 5 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 700 MG, QD | 700 | MG | 0 | 700 | MG | QD | |||||
| 127257591 | 12725759 | 6 | SS | MESNA. | MESNA | 1 | Intravenous (not otherwise specified) | UNK | 0 | SOLUTION FOR INJECTION/INFUSION | |||||||||
| 127257591 | 12725759 | 7 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 8 | C | INNOHEP | TINZAPARIN SODIUM | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 9 | C | NEORECORMON | ERYTHROPOIETIN | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 10 | C | THYROZOL | METHIMAZOLE | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 11 | C | LUTHER | 2 | 0 | |||||||||||||
| 127257591 | 12725759 | 12 | C | DUPHALAC | LACTULOSE | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 13 | C | IMOVANE | ZOPICLONE | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 14 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127257591 | 12725759 | 15 | C | LYRICA | PREGABALIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127257591 | 12725759 | 1 | Prophylaxis of nausea and vomiting |
| 127257591 | 12725759 | 2 | Burkitt's lymphoma |
| 127257591 | 12725759 | 3 | Burkitt's lymphoma |
| 127257591 | 12725759 | 4 | Burkitt's lymphoma |
| 127257591 | 12725759 | 5 | Burkitt's lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127257591 | 12725759 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127257591 | 12725759 | Headache | |
| 127257591 | 12725759 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127257591 | 12725759 | 1 | 20160820 | 20160821 | 0 | |
| 127257591 | 12725759 | 2 | 20160820 | 20160820 | 0 | |
| 127257591 | 12725759 | 3 | 20160819 | 20160821 | 0 | |
| 127257591 | 12725759 | 4 | 20160820 | 20160820 | 0 | |
| 127257591 | 12725759 | 5 | 20160819 | 20160819 | 0 | |
| 127257591 | 12725759 | 6 | 20160820 | 20160820 | 0 |